-
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
Proc Natl Acad Sci U S A. 1987 Aug;84(16):5788-92
PMID: 2886992
-
Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice.
J Exp Med. 1994 Nov 1;180(5):1693-703
PMID: 7964455
-
Deactivation of macrophages by transforming growth factor-beta.
Nature. 1988 Jul 21;334(6179):260-2
PMID: 3041283
-
Bacterial cell wall-induced immunosuppression. Role of transforming growth factor beta.
J Exp Med. 1988 Oct 1;168(4):1403-17
PMID: 2971758
-
Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta.
J Exp Med. 1990 Jan 1;171(1):231-47
PMID: 2295877
-
Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium.
J Immunol. 1990 Oct 15;145(8):2514-9
PMID: 2212650
-
Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals.
J Clin Invest. 1991 Mar;87(3):1108-13
PMID: 1999490
-
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.
J Immunol. 1991 May 1;146(9):3012-7
PMID: 1707929
-
Association of circulating receptor Fc gamma RIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-beta.
J Clin Invest. 1991 May;87(5):1773-9
PMID: 1708784
-
Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
J Exp Med. 1991 Sep 1;174(3):539-45
PMID: 1908509
-
Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure.
J Clin Immunol. 1992 Mar;12(2):61-74
PMID: 1313827
-
Transforming growth factor-beta in disease: the dark side of tissue repair.
J Clin Invest. 1992 Jul;90(1):1-7
PMID: 1634602
-
Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism.
Science. 1992 Jul 24;257(5069):545-8
PMID: 1636092
-
Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study.
Ophthalmology. 1992 Jul;99(7):1162-72; discussion 1173
PMID: 1495798
-
Nitric oxide as a secretory product of mammalian cells.
FASEB J. 1992 Sep;6(12):3051-64
PMID: 1381691
-
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.
Nature. 1992 Oct 22;359(6397):693-9
PMID: 1436033
-
Reversal of acute and chronic synovial inflammation by anti-transforming growth factor beta.
J Exp Med. 1993 Jan 1;177(1):225-30
PMID: 8418203
-
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):770-4
PMID: 8421714
-
Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells.
J Immunol. 1993 May 15;150(10):4494-503
PMID: 7683321
-
Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes.
Proc Natl Acad Sci U S A. 1993 May 15;90(10):4577-81
PMID: 8506302
-
Studies on the mechanisms by which transforming growth factor-beta (TGF-beta) protects against allergic encephalomyelitis. Antagonism between TGF-beta and tumor necrosis factor.
J Immunol. 1993 Jul 15;151(2):1116-27
PMID: 8335893
-
Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.
J Exp Med. 1993 Aug 1;178(2):605-13
PMID: 7688028
-
Suppression of arthritis by an inhibitor of nitric oxide synthase.
J Exp Med. 1993 Aug 1;178(2):749-54
PMID: 7688035
-
Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase.
Science. 1993 Sep 10;261(5127):1445-8
PMID: 7690156
-
Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation.
J Immunol. 1993 Oct 1;151(7):3672-81
PMID: 7690809
-
One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing.
J Clin Invest. 1993 Dec;92(6):2841-9
PMID: 8254038
-
The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.
J Exp Med. 1994 Feb 1;179(2):651-60
PMID: 7507509
-
Transforming growth factor beta: a matter of life and death.
J Leukoc Biol. 1994 Mar;55(3):401-9
PMID: 8120457
-
Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice.
Proc Natl Acad Sci U S A. 1994 May 24;91(11):5187-91
PMID: 8197206
-
Maternal rescue of transforming growth factor-beta 1 null mice.
Science. 1994 Jun 24;264(5167):1936-8
PMID: 8009224
-
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.
Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6688-92
PMID: 8022835
-
Immune dysregulation in TGF-beta 1-deficient mice.
J Immunol. 1994 Sep 1;153(5):1936-46
PMID: 8051399
-
Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta.
Science. 1987 Sep 11;237(4820):1333-6
PMID: 2442813